25 September 2026
The single exit price for medicines will rise 2.88% from October as the industry warns rising input costs are straining medicine supply.
25 August 2026
GLP-1 generics could cut obesity drug costs, challenge illegal sales and expand access as more semaglutide products seek approval.
19 August 2026
The AIDS drug tender dispute deepens as the Health Department defends its R15.5bn HIV procurement process ahead of a September court hearing.
14 August 2026
Black-owned pharmaceutical companies urge the Health Department to revise its tenders, increase local support, and address market inequality.
13 August 2026
Explore the calls for drug company nationalisation in South Africa amid rising job cuts and concerns in the pharmaceutical industry.
12 August 2026
The future of local pharmaceutical manufacturing is at stake. Understand the tensions between government policies and industry needs.
7 August 2026
Local pharmaceutical manufacturing is under pressure as state tenders favour low prices, threatening jobs, medicine supply and investment.
9 July 2026
Slow patent reform is blocking access to lifesaving medicines in South Africa, affecting public healthcare and affordability.
18 June 2026
Explore European drug-pricing policies and how they impact healthcare spending and patient access to life-saving medicines.
11 June 2026
Learn how reliance on imported medicines threatens South Africa's jobs and the industry's pharmaceutical security.
8 April 2026
The 1.47% increase in medicine prices faces legal challenges, as manufacturers demand transparency and an urgent inflation-linked adjustment.
11 March 2026
Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.